ICUI Q1 Deep Dive: Infusion Systems and Consumables Offset Vital Care Weakness
ICU Medical (NASDAQ:ICUI) reported first-quarter 2026 revenue of $526 million, representing 1% organic growth and a 12% decline on a reported basis, as the company continues to lap the mid-2025 creation...
ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results...
ICU Medical Earnings: What To Look For From ICUI
3 Reasons to Avoid ICUI and 1 Stock to Buy Instead
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of...
NEW YORK , April 16, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ICU Medical, Inc. (NASDAQ: ICUI) on behalf of the company's shareholders. The investigation...
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Teardown: ICU Medical (NASDAQ:ICUI) Vs The Rest